Xi Jinping Warns That Chinese Laboratories Handling Deadly Pathogens Will Face Closer Scrutiny
Russia-Led Security Bloc Sets out to Create Special Council on Biosafety
Putin Signs Law on Biosafety in Russian Federation
China Passes First Biosecurity Law in Wake of Covid-19 Pandemic
FDA, NIH Look to Streamline Oversight of Gene Therapies
Biosafety and the Agents of Doom
Biohackers Disregard US FDA Warning on DIY Gene Therapy
FDA warns against ‘do it yourself’ gene therapy kits
DIY Biohacking Can Change the World, if the Government Allows It
Biological agents: Managing the risks in laboratories and healthcare premises
Guiding Principles for Biosafety Governance: Ensuring Institutional Compliance with Biosafety, Biocontainment, and Laboratory Biosecurity Regulations and Guidelines
Biological agents: Managing the risks
Preparing for Future Products of Biotechnology (2017)
GAO-16-642: High Containment Laboratories – Improved Oversight of Dangerous Pathogens Needed to Mitigate Risk
European Biosecurity Awareness Raising Network Review Series on Science and Biosecurity Paper n°1 Security and Dual Use Issues in Neurosciences
Overview on Italian Policy and Institutions on Prevention of Biological Weapons, BWC, and Biosecurity
European Union legislation and recommendations related to biosafety and biosecurity
Russian Federation Chief Health Inspector Order No. 4
The Biological Agents and Genetically Modified Organisms (Contained Use) Regulations 2010
Guidelines and Handbook for Institutional Biosafety Committees (IBSCs)
